Are your patients at increased risk of severe illness from COVID-19?

Pfizer’s Antiviral COVID-19 Clinical Trials

Pfizer is conducting clinical trials to find out if an oral antiviral study medicine, called ibuzatrelvir, is safe, effective, and can work to slow down progression of symptomatic COVID-19 to severe illness.

Pfizer’s Antiviral COVID-19 Clinical Trials

Are your patients at increased risk from COVID-19?

ASPIRE-HR is a Phase 3 clinical trial evaluating oral ibuzatrelvir. This trial will assess the safety, efficacy, and tolerability of ibuzatrelvir compared with placebo in non-hospitalised, symptomatic adult and adolescent participants with COVID-19 who are at high risk of progressing to severe illness.

Learn More >

Are your patients at increased risk of severe illness from COVID-19?

They may be eligible for one of Pfizer’s COVID-19 Clinical Trials.

To find out more about Ibuzatrelvir, COVID-19 clinical trials, and how to refer patients, please complete the contact form below and a member of the Pfizer Field Medical team will contact you.

Contact Form

This contact form is intended to be completed by healthcare professionals only. Please DO NOT submit any patient data in the contact form.

Title

Last Name

First Name

Speciality

City

Zip Code/Postal Code

State/Province

Institution

E-Mail

Phone number

Communication preference – select all that apply

By email
By phone

Areas of Interest

COVID-19 clinical trials
ASPIRE-HR
How to refer a patient

Layout Interest Code/Postal

Disclaimer

I, a healthcare professional, confirm that the information entered in the contact form is my personal information and does not include any patient data.

Disclaimer

I agree to be contacted via email or phone, as I would like to receive more information about Pfizer’s COVID-19 Clinical Trials. I have read and understood further information regarding data protection. I can revoke this consent at any time.

Disclaimer

The use of your personal data complies with applicable law and our privacy policy which can be found here.